Insys Founder Says 'Spillover Prejudice' Warrants New Trial

Law360 (March 2, 2021, 7:12 PM EST) -- The founder of opioid maker Insys Therapeutics insisted Tuesday he deserves a new trial on his landmark racketeering conviction, telling a federal appeals court the outcome was adulterated by "spillover prejudice" from emotional testimony on counts that were gutted only after the verdict.

Founder John Kapoor told the First Circuit that the jury was able to hear highly emotional testimony from opioid patients related to Racketeer Influenced and Corrupt Organizations Act conspiracy predicates that were dismissed after the verdict. This testimony was unrelated to the RICO conspiracy mail and wire fraud predicates that remained standing, and it irreparably biased the jury,...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!